Cargando…
CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma
BACKGROUND: In clinical applications of CAR T-cell therapy, life-threatening adverse events including cytokine release syndrome and neurotoxicity can lead to treatment failure. Outcomes of patients treated with anti-CD30 CAR T- cell have been disappointing in relapsing/refractory (r/r) classical Hod...
Autores principales: | Xue, YuanBo, Lai, Xun, Li, RuiLei, Ge, ChunLei, Zeng, BaoZhen, Li, Zhen, Fu, QiaoFen, Zhao, LiuFang, Dong, SuWei, Yang, JinYan, Guo, JiYin, Meng, QingYin, Tan, QingHua, Li, ZhenHui, Ding, HaiYan, Zhang, YanLei, Liu, ShaoHui, Chang, Alex H., Yao, Hong, Luo, RongCheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885818/ https://www.ncbi.nlm.nih.gov/pubmed/33604290 http://dx.doi.org/10.3389/fonc.2020.607362 |
Ejemplares similares
-
Knockdown of STIM1 expression inhibits non-small-cell lung cancer cell proliferation in vitro and in nude mouse xenografts
por: Ge, Chunlei, et al.
Publicado: (2019) -
Prognostic value of tumor-infiltrating lymphocytes in melanoma: a systematic review and meta-analysis
por: Fu, Qiaofen, et al.
Publicado: (2019) -
Phase I clinical trial of a novel autologous modified-DC vaccine in patients with resected NSCLC
por: Ge, Chunlei, et al.
Publicado: (2017) -
Increased expression of the RNA-binding motif protein 47 predicts poor prognosis in non-small-cell lung cancer
por: Li, Ruilei, et al.
Publicado: (2020) -
Curcumin inhibits cell proliferation and migration in NSCLC through a synergistic effect on the TLR4/MyD88 and EGFR pathways
por: Zhang, Lanfeng, et al.
Publicado: (2019)